U
BSPM

UBS’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

UBS’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Buy
288
+169
+142% +$1.88K ﹤0.01% 9895
2014
Q2 		$1K Sell
119
-571
-83% -$6.31K ﹤0.01% 10308
2014
Q1 		$10K Buy
690
+249
+56% +$3.95K ﹤0.01% 8948
2013
Q4 		$7K Buy
441
+18
+4% +$195 ﹤0.01% 9381
2013
Q3 		$3K Buy
423
+304
+255% +$1.67K ﹤0.01% 9853
2013
Q2 		$1K Buy
+119
New +$662 ﹤0.01% 10102

Other funds holding BSPM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS's BSPM Position: Q3 2014 in Review

UBS increased its Biostar Pharmaceuticals, Inc. (BSPM) stake by 142% in Q3 2014, buying an estimated $1.88K and bringing the position to 288 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #9895.

UBS first reported a position in BSPM in Q2 2013 and has held it in 6 quarters since. The position peaked at $10K in Q1 2014. 11 funds tracked by Wall St. Rank hold BSPM as of Q3 2014.

  • UBS held 288 shares of Biostar Pharmaceuticals, Inc. worth $3K as of Q3 2014.
  • UBS bought 169 Biostar Pharmaceuticals, Inc. shares in Q3 2014, an estimated $1.88K.
  • Biostar Pharmaceuticals, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9895 holding.
  • UBS first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Biostar Pharmaceuticals, Inc. position peaked at $10K in Q1 2014.
  • 11 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.